Despite major advances in methodology, the drug discovery and development process is still likely to take around seven years from new target to regulatory approval. Success requires close co-operation of talented multidisciplinary teams. With the trend away from empirical screening for anti-cancer activity to new mechanism-based approaches targeted to specific molecular abnormalities responsible for cancer, we are now screening a range of exciting new agents emerging for clinical evaluation.

0 0

Post a comment